Aspira Pathlab & Diagnostics Ltd
BSE:540788
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Aspira Pathlab & Diagnostics Ltd
Other Current Assets
Aspira Pathlab & Diagnostics Ltd
Other Current Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Aspira Pathlab & Diagnostics Ltd
BSE:540788
|
Other Current Assets
₹1.8m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
|
Medinova Diagnostic Services Ltd
BSE:526301
|
Other Current Assets
₹476k
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
Dr. Lal PathLabs Ltd
NSE:LALPATHLAB
|
Other Current Assets
₹268m
|
CAGR 3-Years
24%
|
CAGR 5-Years
14%
|
CAGR 10-Years
19%
|
|
|
Metropolis Healthcare Ltd
NSE:METROPOLIS
|
Other Current Assets
₹418.8m
|
CAGR 3-Years
33%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
Aspira Pathlab & Diagnostics Ltd
Glance View
Aspira Pathlab & Diagnostics Ltd. engages in the operation of diagnostic centers and laboratories. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2017-12-05. The principal activities of the Company consist of pathology investigation services, radiology investigation services and other related healthcare services at diagnostic centers in Mumbai. The firm carries out pathological investigations in various branches, including bio-chemistry, hematology, histopathology, microbiology, immuno-chemistry, immunology, virology, cytology, other pathological and radiological investigations. The firm's tests include COVID-19 tests, health packages and pathology tests. Its COVID-19 tests include Shanti Screening Test, COVID-19 Antibody Test, COVID-19 Surveillance Profile, COVID-19 RT-PCR Test, COVID-19 Detection Profile 1 and others.
See Also
What is Aspira Pathlab & Diagnostics Ltd's Other Current Assets?
Other Current Assets
1.8m
INR
Based on the financial report for Dec 31, 2025, Aspira Pathlab & Diagnostics Ltd's Other Current Assets amounts to 1.8m INR.
What is Aspira Pathlab & Diagnostics Ltd's Other Current Assets growth rate?
Other Current Assets CAGR 5Y
-8%
Over the last year, the Other Current Assets growth was 32%. The average annual Other Current Assets growth rates for Aspira Pathlab & Diagnostics Ltd have been -13% over the past three years , -8% over the past five years .
